Study protocol for a randomized single-center cross-over study: Dapagliflozin treatment in recurring kidney stone patients

• Haris Omić,

  Roles Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria

  https://orcid.org/0000-0001-6285-7972

  ⨯
• Michael Eder,

  Roles Conceptualization, Writing – review & editing

  Affiliation Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria

  ⨯
• Harald Herkner,

  Roles Methodology, Software

  Affiliation Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria

  ⨯
• Christian Seitz,

  Roles Conceptualization, Resources, Supervision

  Affiliation Department of Urology, Medical University of Vienna, Vienna, Austria.

  ⨯
• Željko Kikić ,

  Contributed equally to this work with: Željko Kikić, Tarek Arno Schrag

  Roles Conceptualization, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: zeljko.kikic@meduniwien.ac.at

  Affiliation Department of Urology, Medical University of Vienna, Vienna, Austria.

  https://orcid.org/0000-0002-0093-5389

  ⨯
• Tarek Arno Schrag

  Contributed equally to this work with: Željko Kikić, Tarek Arno Schrag

  Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria

  ⨯